Latest on Coronavirus pandemic Medical technology

New Post Public Reply Private Reply Replies (1) Message Board
Crunch55
496


Latest on Coronavirus pandemic
Medical technology gives healthcare a shot in the arm
Coronavirus latest: US hospitalisations top 80,000 for first time
European weekly ETF inflows hit highest level this year
The extra mile: how Covid-19 transformed exercise
Coronavirus pandemic Add to myFT
Slovakia’s mass coronavirus testing finds 57,500 new cases
High participation in landmark screening programme identifies previously unknown hotspots

Slovakia used antigen tests, which deliver results in as little as 15 minutes but are less accurate than the standard PCR tests © Zuzana Gogova/Getty
Share on Twitter (opens new window)
Share on Facebook (opens new window)
Share on LinkedIn (opens new window)
Save
James Shotter in Warsaw NOVEMBER 10 2020
19
Print this page
Be the first to know about every new Coronavirus story
Get instant email alerts

An attempt to test almost the entire population of Slovakia for coronavirus identified 57,500 new infections, according to official figures from the landmark programme that has been closely watched by other countries.

The central European country tested 3.6m people — two-thirds of its population — on 31 October and 1 November using rapid antigen tests, before testing a further 2m people in the worst-hit regions — some for the second time — last weekend.

Despite long queues at some screening centres during the first weekend, fears that a lack of staff would stymie the project were unfounded. Participation was high with 80-90 per cent of eligible people taking part in the first weekend of testing and some previously unknown hotspots, such as in the district of Puchov, were identified.

In total, during the two weekends and a trial run in two badly hit regions a week earlier, 57,462 people tested positive, and were sent into quarantine along with their families, according to official figures. The country’s standard polymerase chain reaction, or PCR, testing has separately found 77,123 cases since the start of the pandemic.

Slovakia is the first EU nation to test its entire population so quickly, and the experiment was watched by health officials across the continent desperate to contain the second wave of the pandemic. The UK sent four officials to Slovakia to observe, and last weekend began a similar mass screening programme using antigen tests in the city of Liverpool.


People queue for a test in Bratislava on October 31 © Vladimir Simicek/AFP/Getty

British Army soldiers staff a coronavirus testing centre in Liverpool, north-west England, on Tuesday © Oli Scarff/AFP/Getty
Igor Matovic, Slovakia’s prime minister, said on Monday that the infection rate in regions that were tested in both rounds of screening dropped from 1.47 per cent in the first weekend to 0.62 per cent in the second. This, he said, meant that antigen testing was a very effective tool for fighting the pandemic.

“[When] I came up with the idea of mass testing . . . all sorts of opinions emerged, that this was complete stupidity and would only make the situation worse,” he said in a statement on Sunday.

“The results? Above all expectations. After [the second round] we can say that mass testing reduces the number of infectious people from week to week by 55 per cent! Which is amazing.”

Other experts were more cautious. Rather than PCR tests which are considered the gold standard for spotting coronavirus, Slovakia used antigen tests, which deliver results in as little as 15 minutes but are less accurate.

“We don’t know how many of those who tested negative are really negative,” said Professor Vladimir Krcmery, an expert on tropical and infectious diseases, who helped carry out the testing. “[Antigen tests] are not as sensitive as the PCR test, but you do catch the most infectious people.”

Recommended
Coronavirus pandemic
Coronavirus tracked: has the epidemic peaked near you? | Free to read

Experts also cautioned that the drop in relative levels of infection across the two rounds of testing could not be attributed only to the impact of the testing itself.

“It is clear that the 55 per cent reduction in prevalence cannot be attributed only to mass testing,” said Martin Smatana, former head of Slovakia’s Institute of Health Policies. “A large part of the impact must be the result of stricter restrictions and reduced mobility,” he wrote on Facebook.

Prof Krcmery said bigger countries intent on testing their entire population should stagger screening over a longer period. But he said Slovakia’s experience showed that for small countries, rapid mass testing in conjunction with other tools such as quarantines and social distancing, could prove useful for fighting the pandemic.

“I would be very happy if we went back to the situation [in the summer] where we only had sporadic cases. But it would also be a partial success if this exercise means that we get a plateau [in case numbers],” he said.

“A plateau would serve as a bridge between now and the time that a vaccine arrives. But you have to build this bridge. You can’t just wait for cases to go down.”

Latest coronavirus news

Follow FT's live coverage and analysis of the global pandemic and the rapidly evolving economic crisis here.

Get alerts on Coronavirus pandemic when a new story is published

Get alerts
Copyright The Financial Times Limited 2020. All rights reserved.
Reuse this content(opens in new window)
Latest on Coronavirus pandemic
Life & Arts
The extra mile: how Covid-19 transformed exercise
NEW

Exchange traded funds
European weekly ETF inflows hit highest level this year
NEW

Coronavirus pandemic
Coronavirus latest: US hospitalisations top 80,000 for first time
NEW

Special ReportFT Intelligent Business
Medical technology gives healthcare a shot in the arm
NEW

Follow the topics in this article
Coronavirus pandemic
Add to myFT
Slovakia
Add to myFT
James Shotter
Add to myFT

Feedback
Useful links
Support
View Site Tips
Help Centre
About Us
Accessibility
myFT Tour
Careers
Legal & Privacy
Terms & Conditions
Privacy Policy
Cookies
Copyright
Slavery Statement & Policies
Services
FT Live
Share News Tips Securely
Individual Subscriptions
Group Subscriptions
Republishing
Contracts & Tenders
Executive Job Search
Advertise with the FT
Follow the FT on Twitter
FT Transact
Secondary Schools
Tools
Portfolio
Today's Newspaper (ePaper)
Alerts Hub
MBA Rankings
Enterprise Tools
News feed
Newsletters
Currency Converter
More from the FT Group
Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2020. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Close drawer menuFinancial Times
International Edition

Switch to UK Edition
Top sections
Home
World
Show more World
US
Show more US
Companies
Show more Companies
Tech
Markets
Show more Markets
Climate
Graphics
Opinion
Show more Opinion
Life & Arts
Show more Life & Arts
Personal Finance
Show more Personal Finance
How to Spend It
Special Reports
FT recommends
Lex
Alphaville
Lunch with the FT
FT Globetrotter
#techAsia
Moral Money
FTfm
Newsletters
Video
Podcasts
News feed
myFT
Portfolio
Today's Newspaper (ePaper)
Crossword
Our Apps
Help Centre
Subscribe
Sign In

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Updated Category News Views 25

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Continue Reading
Xi Jinping's Vision for China's Financial Evolution

Updated Category News Views 174

Xi's Blueprint for Financial Strength Xi Jinping isn't just whistling Dixie when it comes to reshaping China's financial landscape. His vision is about more than pushing paper; it's about embedding honesty, prudence, and traditional values into the very DNA of China's financial sector. When he talks about enhancing both hard and soft power, he’s thinking wider than...

Continue Reading
Curaleaf Eyes Aurora Amid Alternative from Organigram

Updated Category News Views 65

Curaleaf's Determined Pursuit of Aurora Another day, another chess move in the cannabis world. Curaleaf is standing tall amid talk of a buyout, putting a foot forward to highlight its determination in the battle for Aurora. They've put forth an alternative to the proposal poised by Organigram, raising stakes and eyebrows alike. Aurora Cannabis is in the middle of a dance...

Continue Reading
PRIMA Invests £10M to Propel CC Forum's Global Reach

Updated Category News Views 123

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Continue Reading
Pyramid Pharma Takes On 13th Blood Cancer Therapy Product

Updated Category News Views 64

Pyramid Pharma: Breaking New Ground in Blood Cancer Treatments There's a new player making waves in the battle against rare blood cancers: Pyramid Pharma Services. This U.S.-based contract development and manufacturing organization is stepping up its game by finessing a cartridge-based product designed to treat those rare and tricky blood maladies. The canvas? A...

Continue Reading
Class Action Targets Coastal Financial Over Missteps

Updated Category News Views 32

New Crosshairs on Coastal Financial Corporation Man, it's another day and yet another fiasco in the corporate world. Late-breaking news from the trenches alerts us that Coastal Financial Corporation is in the legal spotlight. Yeah, you heard me right. We're talking about NASDAQ:CCB, the darlings turned defendants courtesy of recent allegations that could rock their stock....

Continue Reading
Atlas-SSI Expands Grip in Water Control Space

Updated Category News Views 86

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Continue Reading
Cloud Software Group Amends $2B Cash Tender Offer

Updated Category News Views 22

Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 51

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
Multiconsult's Q3 2026 Results: A Gradual Rebound

Updated Category News Views 30

Peering into the Q3 Crystal Ball When a company drops its quarterly results, it's like unveiling a new episode in an ongoing drama, and the Multiconsult ASA (Oslo: MULTI) saga is no exception. In their third quarter of 2026, the performance started to show signs of life following a somewhat sluggish run. While the numbers aren't sky-high, they're a solid indication that...

Continue Reading

Top 5 Most Recently Viewed Articles

Mobilizing for Equality: Texas AAPI Community Stands United

Updated Category News Views 275

Mobilizing for Equality: Texas AAPI Community Stands United Communities across Texas are coming together in a powerful display of solidarity against discriminatory Senate Bill 17 (SB 17) and House Bill 17 (HB 17). Both pieces of legislation propose to ban or severely restrict real estate ownership for certain foreign nationals, all while cloaked in the guise of protecting...

Continue Reading
Duke Energy Foundation's Commitment to Community Resilience Grows

Updated Category News Views 252

Duke Energy Foundation's Commitment to Community Resilience Duke Energy Foundation, along with Duke Energy, has made a significant impact by investing over $33 million in nonprofit organizations. This funding supports efforts aimed at enhancing community resilience, emergency preparedness, and disaster relief activities. The partnership extends across multiple states,...

Continue Reading
eCential Robotics Announces New Leaders to Boost Growth in US

Updated Category News Views 111

eCential Robotics Welcomes New Leadership to Accelerate Growth in the U.S. eCential Robotics, an innovator in surgical robotics, is thrilled to announce the recent appointments of Lisa Jacobs as President for North America and Matthieu Ville as Vice President of Marketing. These strategic hires are designed to bolster the company's growth and innovation efforts in the...

Continue Reading
Michelin's Latest Share Buyback Update Everyone Should Know

Updated Category News Views 220

Understanding Michelin's Share Buyback Program Michelin, a leader in tire manufacturing and innovation, is continuously taking steps to enhance its shareholder value. Investors often look for tangible actions reflecting a company's commitment to their financial growth. One of the most significant methods companies utilize to support their stock price and return capital to...

Continue Reading
InterDigital Boosts Third Quarter Forecast Following License Deal

Updated Category News Views 198

InterDigital's Promising New License Agreement and Q3 Outlook Smartphone Licensing Agreement Enhances Revenue Predictions Recently, InterDigital, Inc. (Nasdaq: IDCC), a prominent player in the mobile technology field, announced an exciting update that significantly alters its revenue expectations for the third quarter. The company has secured a major licensing agreement...

Continue Reading